Persistent Cryptococcal Brain Infection despite Prolonged Immunorecovery in an HIV-Positive Patient

Author:

Wingfield Tom12,Baxter Jo2,Herwadkar Amit3,du Plessis Daniel4,Blanchard Tom J.2,Javier Vilar F.2,Varma Anoop56

Affiliation:

1. Section of Infectious Diseases & Immunity and Wellcome Trust, Imperial College Centre for Global Health Research, Imperial College London Hammersmith Hospital Campus, 150 Du Cane Road, London W12 0NN, UK

2. The Monsall Infection Unit, Regional Department of Infectious Diseases and Tropical Medicine, North Manchester General Hospital, Delaunays Road, Manchester M8 5RB, UK

3. Department of Neuroradiology, North Manchester General Hospital, Delaunays Road, Manchester M8 5RB, UK

4. Department of Neuropathology, Salford Royal Hospital, Stott Lane, Salford M6 8HD, UK

5. Department of Neurology, North Manchester General Hospital, Delaunays Road, Manchester M8 5RB, UK

6. Department of Neurology, Salford Royal Hospital, Stott Lane, Salford M6 8HD, UK

Abstract

Background.HIV-positive people starting combined antiretroviral therapy may develop immune reconstitution to latent or treated opportunistic infections. Immune reconstitution to cerebral Cryptococcus is poorly understood and can be fatal.Case Presentation.A 33-year-old Zimbabwean female presented with cryptococcal meningitis and newly diagnosed HIV with a CD4 count of 51 cells/μL (4%). She was treated with amphotericin and flucytosine. Combined antiretroviral therapy was started four weeks later and she showed early improvement. However, over the ensuing 18 months, her clinical course was marked by periodic worsening with symptoms resembling cryptococcal meningitis despite having achieved CD4 counts ≥400 cells/μL. Although initially treated for relapsing cryptococcal immune reconstitution syndrome, a brain biopsy taken 17 months after initial presentation showed budding Cryptococci.Conclusion.This unusually protracted case highlights the difficulties in differentiating relapsing cryptococcal meningitis from immune reconstitution and raises questions concerning the optimum timing of initiation of combined antiretroviral therapy in such patients.

Publisher

Hindawi Limited

Subject

General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3